Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/24/11  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Patrick P. Zarrinkar

Wrong Dr. Patrick P. Zarrinkar?
 
Background

Employment History

Education

  • Ph.D.
    Massachusetts Institute of Technology
11 Total References
Web References
Ambit Biosciences » About Ambit » Management Team
www.ambitbio.com, 23 Feb 2009 [cached]
Patrick P. Zarrinkar, Ph.D. Vice President, Technology Development & Alliance Management
...
Patrick P. Zarrinkar, Ph.D.
Vice President, Technology Development & Alliance Management
Patrick P. Zarrinkar brings a deep understanding of genomics and high throughput screening to Ambit. Prior to joining Ambit in 2000, he was a Staff Scientist at the Genomics Institute of the Novartis Research Foundation (GNF) in San Diego, where he worked in collaboration with Affymetrix, Inc. to develop high throughput methods for global gene expression profiling. Zarrinkar received his Ph.D. from Massachusetts Institute of Technology and conducted postdoctoral research in the lab of Professor Bruce Sullenger at Duke University Medical Center.
C21 BioVentures Conference
www.techvision.com, 20 Dec 2003 [cached]
Patrick ZarrinkarHead of Molecular Biology and Technology Development
...
Dr. Zarrinkar is Head of Molecular Biology and Technology Development at Ambit Biosciences in San Diego, California.He has been with the company since October, 2000.Ambit is a small molecule discovery company that uses its proprietary kinase profiling technology to accelerate and guide small molecule kinase inhibitor development.
Prior to joining Ambit, Dr. Zarrinkar was a Staff Scientist at the Genomics Institute of the Novartis Research Foundation (GNF) in San Diego (1999-2000).At GNF, he worked in collaboration with Affymetrix Inc. to develop high throughput methods for global gene expression profiling.Dr. Zarrinkar received his Ph.D. in 1996 from the Department of Chemistry at the Massachusetts Institute of Technology.He was a postdoctoral fellow in the Center for Genetic and Cellular Therapies of the Department of Surgery at Duke University Medical Center from 1996 to 1999.
Earlier that morning, at 7:45 and ...
www.coldchainpharma.com, 5 Dec 2008 [cached]
Earlier that morning, at 7:45 and in a different location, Patrick Zarrinkar, Ph.D., Ambit's Vice President, Technology Development will present preclinical data generated on AC220 during the New Targeted Drugs (preclinical) session.
On the evening of Sunday, December 7, a poster highlighting the clinical pharmacokinetics and effect of AC220 on FLT3 phosphorylation will be presented from 6:00 to 8:00.
Screening for a family of targets ...
www.genengnews.com, 1 Feb 2006 [cached]
Screening for a family of targets rather than a single target is becoming more common in HTS, says Patrick Zarrinkar, Ph.D., director of molecular biology and technology development at Ambit Biosciences (www.ambitbio.com).The firm offers a new technology to screen compounds against a large panel of kinases as opposed to the traditional approach of screening compounds against a single kinase in a single assay at a given time.
The KinomeScan platform screens small molecule compounds against a panel of 235 kinases simultaneously, providing a fast, accurate, uniform, and quantitative kinase profile for each compound, claims Dr. Zarrinkar.KinomeScan turns the cross-reactivity issue of kinase inhibitors into a discovery advantage, revealing how well compounds bind not only to their intended targets, but also to mutations and unintended targets that may cause side effects or offer new uses for existing drugs, he adds.
Our proprietary technology enables kinase researchers to efficiently perform a high-content and high-throughput screening assay under standardized conditions.We are currently working on expanding our technology to include more kinases in our assay panel, says Dr. Zarrinkar.
Patrick Zarrinkar, Ph.D., ...
www.lifesciencesinfo.com, 5 April 2004 [cached]
Patrick Zarrinkar, Ph.D., Sr. Director, Technology Development & Alliance Management, Ambit Biosciences
...
Patrick Zarrinkar, Ph.D., Sr. Director, Technology Development & Alliance Management, Ambit Biosciences
Other People with the name "Zarrinkar":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304